Medifast (NYSE: MED)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Medifast Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Medifast Company Info
The Company is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products.
News & Analysis
Market-thumping sales growth is holding up through early 2021.
John talks to Tucker Walsh and Rayna Lesser Hannaway, the two portfolio managers of the Polen U.S. Small Company Growth Strategy, about Paycom, EPAM Systems, and more.
Investors took the third-quarter earnings report as an opportunity to book some profits on this high-flying stock.
With the stock market faltering, these popular growth stocks may soon deflate.
When economic growth eventually slows, these industries could be among the first to topple.
Find out which of these stocks got earnings boosts.
Even though the market climbed, these stocks missed out. Find out why.
A cheap global automaker, a clinical-stage biopharmaceutical company with intriguing early-stage results, and a potentially overvalued weight-control company are this week's must-watch stocks.
Valuation
Earnings Transcripts
MED earnings call for the period ending September 30, 2021.
MED earnings call for the period ending June 30, 2021.
MED earnings call for the period ending March 31, 2021.
MED earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.